https://orcid.org/0000-0002-4794-8734
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Objective
Severe asthma is considered a risk factor for SARS-Coronavirus 2 (SARS-CoV-2) infection but scientific evidences are lacking.
Methods
we performed a literature search and review based on PubMed database national, international recommendations as well as papers on severe asthmatic patients and their management during SARS-CoV-2 pandemic.
Results
the majority of international recommendations, expert panels and editorials provide indications about management of severe asthmatic patients. No published studies evaluated the effects of biologic agents on severe asthmatic patients during SARS-CoV-2 pandemic.
Conclusions
the relationship between SARS-CoV-2 and asthma is variable worldwide and severe asthmatic patients were seldom reported in published cohorts. International recommendations suggest maintaining asthma under control to limit exacerbations occurrence, by using all available treatment. The minimum steroid dosage effective to control symptoms should be maintained to avoid exacerbations; biologic agents administration should be regularly scheduled encouraging patient support programmes.
Authors’ contributions
Patrucco Filippo: Conceptualization, Methodology, Writing original draft, Writing review & editing; Benfante Alida: Conceptualization, Methodology, Writing original draft, Writing review & editing; Villa Elisa: Conceptualization, Methodology, Writing original draft; Principe Stefania: Writing original draft, Writing review & editing; Scichilone Nicola: Conceptualization, Methodology, Supervision, Writing review & editing; Solidoro Paolo: Conceptualization, Methodology, Supervision, Writing review & editing. All authors read and approved the final version of the manuscript.
Declaration of interest
The authors report no conflict of interest.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.